Melbourne researchers are helping expand options for people with high cholesterol that puts them at risk of heart attack or stroke, including world-first drugs for potentially deadly conditions.

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

“We have been issued a Form 483 with 7 observations, which we will address within the stipulated timeline,” Dr. Reddy’s said in a filing on Tuesday. It was a GMP inspection of the API manufacturing ...

"Astellas stands by the clinical profile of Izervay, the only FDA-approved GA treatment that consistently demonstrated ...

Lilly's drug is the only oral treatment in a field of several injectable therapies being tested to treat high Lp(a), a risk factor for heart disease that affects one in five individuals globally ...

Two Shreveport agencies have entered into a partnership to support reforming the city’s crisis response system.

People born with inherited high cholesterol — known as the “evil cousin” — may soon have access to new and potentially ...